Bionano announces glass lewis recommendation and encourages stockholders to cast their vote ahead of june 9th annual meeting

San diego, may 26, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced that glass lewis & co., a leading independent proxy advisory firm, has recommended that bionano's stockholders vote in favor of all proposals recommended by bionano's board of directors at the company's 2022 annual meeting of stockholders (details below).
BNGO Ratings Summary
BNGO Quant Ranking